title: A neurohistochemical blueprint for pain-induced loss of appetite.
abstract: A common complaint among pain patients is that they lose their appetite. These accounts are anecdotal, however, and the neural mechanism underlying pain-induced loss of appetite remains unknown. In this study, we documented the occurrence of appetite loss in patients under migraine attack and investigated the neuronal substrate of pain-induced anorexia in our animal model of intracranial pain. We found that loss of appetite during the migraine attack in humans coincided strongly with the onset and duration of the head pain in 32/39 cases, and that brief noxious stimulation of the dura in conscious rats produced a transient suppression of food intake. Mapping of neuronal activation in the rat showed that noxious dural stimulation induced a 3- to 4-fold increase in the number of Fos-positive neurons in medullary dorsal horn areas that process nociceptive signals (laminae I, V) and in parabrachial and hypothalamic neurons positioned to suppress feeding behavior. In the parabrachial area, activated neurons were localized in the superior-lateral subnucleus, and 40% of them expressed the mRNA encoding the anorectic neuropeptide cholecystokinin. In the hypothalamus, activated Fos-positive neurons were found in the dorsomedial area of the ventromedial nucleus, and 76% of them expressed the mRNA for cholecystokinin type-B receptor. Based on these findings, we suggest that at least one of several groups of hypothalamic neurons that normally inhibit appetite in response to metabolic cues is positioned to mediate the suppression of food intake by pain signals.
authors.affiliation: Department of Neurobiology and the Program in Neuroscience, Harvard Medical School, Harvard Institutes of Medicine, Boston, MA 02115, USA.
authors.forename: A
authors.initials: A
authors.lastname: Malick
authors.forename: M
authors.initials: M
authors.lastname: Jakubowski
authors.forename: J K
authors.initials: JK
authors.lastname: Elmquist
authors.forename: C B
authors.initials: CB
authors.lastname: Saper
authors.forename: R
authors.initials: R
authors.lastname: Burstein
mesh_terms: D000818:Animals; D000855:Anorexia / Q000209:etiology / Q000503:physiopathology*; D001933:Brain Stem / Q000378:metabolism*; D002766:Cholecystokinin / Q000096:biosynthesis* / Q000235:genetics; D004388:Dura Mater / Q000503:physiopathology*; D004435:Eating / Q000502:physiology; D004558:Electric Stimulation; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D008881:Migraine Disorders / Q000503:physiopathology / Q000523:psychology; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D009474:Neurons / Q000737:chemistry / Q000502:physiology; D009619:Nociceptors / Q000502:physiology*; D010146:Pain / Q000503:physiopathology* / Q000523:psychology; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000096:biosynthesis* / Q000235:genetics; D014278:Trigeminal Nuclei / Q000378:metabolism; D014697:Ventromedial Hypothalamic Nucleus / Q000378:metabolism*
chemical_list: D009419:Nerve Tissue Proteins; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin